Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
株式のランク #17926
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
株価
$18.20
最終同期: 2025-05-09
時価総額
$220.35M
変化(1日)
-5.34%
変化(1年)
0.00%
JP
取引 I'rom Group Co., Ltd. (2372)

カテゴリー

I'rom Group Co., Ltd.(2372)のP/B比率
September 2026 時点のP/B比率 TTM: 2.64
I'rom Group Co., Ltd. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 2.64 です。2023 年末時点でのP/B比率は 1.88 でした。
I'rom Group Co., Ltd. の P/B 比率の履歴(2005 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
2026 (TTM) 2.64 51.13%
2024 1.75 -7.25%
2023 1.88 -17.84%
2022 2.29 -32.09%
2021 3.38 59.04%
2020 2.12 -27.92%
2019 2.95 -52.22%
2018 6.16 81.16%
2017 3.40 0.32%
2016 3.39 -14.29%
2015 3.96 142.80%
2014 1.63 25.60%
2013 1.30 17.04%
2012 1.11 50.67%
2011 0.74 -10.38%
2010 0.82 -13.31%
2009 0.95 48.53%
2008 0.64 -38.17%
2007 1.03 -74.98%
2006 4.12 -70.24%
2005 13.85 0.00%
同業他社のP/B比率